Assess practicalities, scalability and impact of implementation of 99DOTS adherence technology for 1000 DS-TB patients that receive treatment with FDC medication in mining regions. This will facilitate self-administration and identification of high risk patients to efficiently allocate HCW’s time and counselling support to those patients most in need.
